ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2986

Systemic Sclerosis Patients on Intensive Care Unit – Reasons for Admission and Determinants of Outcome

Svetlana I. Nihtyanova1, Francesco Figorilli2, Christopher P. Denton3, Banwari Agarwal2 and Voon H. Ong1, 1Rheumatology, UCL Division of Medicine, London, United Kingdom, 2ITU, Royal Free Hospital, London, United Kingdom, 3Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Intensive care, outcomes, scleroderma and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Little has been published on systemic sclerosis (SSc) patients requiring admission to Intensive Care Unit (ICU) for organ support; published results suggest respiratory failure due to end-stage lung disease the most frequent reason for admission and need for mechanical ventilation a significant predictor of poor outcome.

Methods:

Retrospective case note review of consecutive SSc patients admitted to ICU over a fifteen year period was analysed for patient demographic and disease characteristics, acute precipitating event, end organ damage requiring organ system support on ICU and outcome.

Results:

Fifty-one SSc patients were identified, 80%  female, 43% with diffuse cutaneous SSc and 41% with overlap syndromes; 24% (n=12) had clinically significant pulmonary fibrosis (PF), 12% (n=6) had pulmonary hypertension (PH), 14% (n=7) had cardiac SSc, 29% (n=15) had SSc renal crisis (SRC) and 12% (n=6) had severe SSc bowel involvement.

Sepsis (37%, n=19), pneumonia in particular (n=16), accounted for the single most frequent precipitant requiring ICU admission. Other primary reasons for admission included SRC (8%, n=4), cardiac (4%, n=2), neurological (6%, n=3) and non-infective pulmonary causes (6%, n=3). A large proportion of patients (29%, n=15) were on ICU post elective surgery.

All surgical, neurological or SRC admissions survived to ICU and hospital discharge. Sepsis on the other hand was associated with nearly 4 times higher risk of death within 1 year from ICU admission (HR 3.8, p=0.002) with 52% of these patients dying while on ICU compared to 13% of the other admissions (p=0.003).

Elective surgical patients spent up to 3 days on ICU, while the medical (n=33) and emergency surgical admissions (n=3) spent between 1 and 45 days (median 4, IQR 1, 19). On the day of admission 22% (n=8) required non-invasive mechanical ventilation, 61% (n=22) invasive mechanical ventilation, 22% (n=8) renal replacement therapy and 36% (n=13) vasopressors. Fourteen (39%) died while on ICU. While the use of mechanical ventilation and renal replacement therapy was not associated with negative short-term outcome, patients who needed vasopressor therapy were at nearly 6 times higher odds of dying while on ICU (OR 5.7, p=0.011).

Overall survival from ICU admission was 67% on day 7, 56% at 1 month and 44% at 1 year. Gender, subset, antibody specificities and overlap features did not associate with survival after ICU admission. On the other hand, compared to patients without significant organ involvement, those with PH had nearly 8 time increase of the risk of death (HR 7.7, p=0.024) and those with severe bowel disease had more than 5 times increase in the risk of death (HR 5.5, p=0.020). SRC on the other hand, was associated with good prognosis (HR 0.2, p=0.010).

Conclusion:

ICU outcomes of patients with underlying SSc seem to be better than previously reported, with best prognosis observed in post-surgical and SRC patients. Sepsis and pneumonia are most common medical precipitating events and are associated with poor prognosis. Mechanical ventilation and renal replacement therapy need is likely to reflect severity of underlying chronic disease and acute derangement and their use therefore should be guided by the overall clinical context.


Disclosure: S. I. Nihtyanova, None; F. Figorilli, None; C. P. Denton, GlaxoSmithKline, 2,Actelion Pharmaceuticals US, 5,GlaxoSmithKline, 5,Serono, 5,Inventiva, 5,CSL Behring, 2,Bayer, 5; B. Agarwal, None; V. H. Ong, None.

To cite this abstract in AMA style:

Nihtyanova SI, Figorilli F, Denton CP, Agarwal B, Ong VH. Systemic Sclerosis Patients on Intensive Care Unit – Reasons for Admission and Determinants of Outcome [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/systemic-sclerosis-patients-on-intensive-care-unit-reasons-for-admission-and-determinants-of-outcome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-sclerosis-patients-on-intensive-care-unit-reasons-for-admission-and-determinants-of-outcome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology